• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病行为改变可能的神经递质基础。

Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

作者信息

Palmer A M, Stratmann G C, Procter A W, Bowen D M

机构信息

Miriam Marks Department of Neurochemistry, Institute of Neurology, Unversity of London, UK.

出版信息

Ann Neurol. 1988 Jun;23(6):616-20. doi: 10.1002/ana.410230616.

DOI:10.1002/ana.410230616
PMID:2457353
Abstract

Serotonin, 5-hydroxyindoleacetic acid, and homovanillic acid concentrations have been determined in 10 areas of the cerebral cortex from 17 subjects with Alzheimer's disease and 18 control subjects. The dopamine metabolite was not reduced in any area, whereas both indoleamines were reduced in the superior frontal, inferior temporal, and fusiform gyri, and the temporal pole. These areas and areas of the parietal cortex, where there were no changes in concentration, have not previously been reported on. We argue that the large loss of indoleamines from the frontal lobe (to 50-63% of control values) is rather unexpected based on other biochemical measurements and may relate to behavioral changes.

摘要

已测定了17名阿尔茨海默病患者和18名对照者大脑皮质10个区域中血清素、5-羟吲哚乙酸和高香草酸的浓度。多巴胺代谢物在任何区域均未减少,而两种吲哚胺在额上回、颞下回、梭状回和颞极均减少。顶叶皮质中浓度未发生变化的这些区域以及其他区域,此前未见报道。我们认为,基于其他生化测量,额叶中吲哚胺大量减少(降至对照值的50%-63%)相当出乎意料,且可能与行为变化有关。

相似文献

1
Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.阿尔茨海默病行为改变可能的神经递质基础。
Ann Neurol. 1988 Jun;23(6):616-20. doi: 10.1002/ana.410230616.
2
Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.阿尔茨海默病-老年痴呆症中的生化变化:阿尔茨海默型老年痴呆症中的神经递质。
Res Publ Assoc Res Nerv Ment Dis. 1979;57:153-66.
3
Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder.神经元核内包涵体病中的脑内神经递质异常。
Ann Neurol. 1985 Apr;17(4):405-7. doi: 10.1002/ana.410170419.
4
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
N Engl J Med. 1985 Jul 4;313(1):7-11. doi: 10.1056/NEJM198507043130102.
5
Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.阿尔茨海默病:基底核中单胺和螺哌隆结合减少。
Ann Neurol. 1986 Jun;19(6):602-4. doi: 10.1002/ana.410190616.
6
Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.阿尔茨海默病患者大脑皮质中生长抑素样免疫反应性广泛降低。
Ann Neurol. 1986 Oct;20(4):489-95. doi: 10.1002/ana.410200408.
7
Significance of neurotransmitter abnormalities in Alzheimer's disease.阿尔茨海默病中神经递质异常的意义。
Res Publ Assoc Res Nerv Ment Dis. 1986;64:279-86.
8
Central neurotransmitter effects of organotin compounds: trials, tribulations and observations.有机锡化合物的中枢神经递质效应:试验、磨难与观察
Neurotoxicology. 1984 Summer;5(2):267-77.
9
A postmortem study of amino acid neurotransmitters in Alzheimer's disease.阿尔茨海默病中氨基酸神经递质的尸检研究。
Ann Neurol. 1986 Nov;20(5):616-21. doi: 10.1002/ana.410200510.
10
Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.皮质生长抑素、神经肽Y和NADPH黄递酶神经元:正常解剖结构及阿尔茨海默病中的改变
Ann Neurol. 1988 Feb;23(2):105-14. doi: 10.1002/ana.410230202.

引用本文的文献

1
Analysis of human brain RNA-seq data reveals combined effects of 4 types of RNA modifications and 18 types of programmed cell death on Alzheimer's disease.对人类大脑RNA测序数据的分析揭示了4种RNA修饰和18种程序性细胞死亡对阿尔茨海默病的联合作用。
J Transl Med. 2025 Apr 3;23(1):396. doi: 10.1186/s12967-025-06324-6.
2
Extracts of and Alleviate Cognitive Impairments in Scopolamine-Induced Rat Dementia.及 提取物可缓解东莨菪碱诱导的大鼠痴呆认知障碍。
Int J Mol Sci. 2024 Feb 2;25(3):1840. doi: 10.3390/ijms25031840.
3
The Interface between Depression and Alzheimer's Disease. A Comprehensive Approach.
抑郁症与阿尔茨海默病的关联。一种综合方法。
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):315-325. doi: 10.4103/aian.aian_326_23. Epub 2023 Sep 11.
4
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares.采用多模态偏最小二乘法对晚年抑郁症的血清素退化和β-淀粉样蛋白沉积进行正电子发射断层扫描成像。
Transl Psychiatry. 2021 Sep 13;11(1):473. doi: 10.1038/s41398-021-01539-9.
5
Molecular imaging of serotonin degeneration in mild cognitive impairment.轻度认知障碍中5-羟色胺退变的分子成像
Neurobiol Dis. 2017 Sep;105:33-41. doi: 10.1016/j.nbd.2017.05.007. Epub 2017 May 13.
6
Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment.轻度认知障碍中血清素去神经支配与静息态功能连接之间的关联
Hum Brain Mapp. 2017 Jul;38(7):3391-3401. doi: 10.1002/hbm.23595. Epub 2017 Apr 5.
7
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.β-淀粉样蛋白和磷酸化tau蛋白的积累导致阿尔茨海默病神经元突触异常。
J Alzheimers Dis. 2017;57(4):975-999. doi: 10.3233/JAD-160612.
8
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?阿尔茨海默病中的神经精神障碍:我们从神经病理学研究中学到了什么?
Curr Alzheimer Res. 2016;13(10):1145-64. doi: 10.2174/1567205013666160502123607.
9
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.针对衰老和阿尔茨海默病中MAO、胆碱酯酶、铁和β-淀粉样蛋白的多方面混合制剂的神经保护作用
Br J Pharmacol. 2016 Jul;173(13):2080-94. doi: 10.1111/bph.13318. Epub 2015 Dec 1.
10
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.阿尔茨海默病和帕金森病神经精神症状的分子成像
Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Epub 2014 Nov 20.